No animus, Snark. Why would there be? Is that what

New Post Public Reply Private Reply Replies (1) Message Board
JayDee Snark #20640
632
No animus, Snark. Why would there be?

Is that what we're all doing here? Saying nothing until "there's evidence to support?" If you insist on beating that drum, please list for everyone all of the evidence that Squires is simply doing his best to avoid violating SEC rules. Or is it that he's prohibited from disclosing facts to shareholders by NDAs? I cant remember which excuse Puravida thought was "supported by evidence" this time. Maybe because theres too much evidence supporting them. With all of those facts, I'm sure you'll have a long list itemizing evidence for us to read.

By the way, there isn't a lack of evidence problem. Theres plenty of that. There's a concealment of evidence problem. I can assure you, concealment itself is evidence.

And yes, being a lawyer, I have a pretty good idea how law firms work. But if that bothers you, do what Puravida does and cite the "internet's veil of anonymity" to support the idea that your speculation about how law firms work is of equal weight to my actual experience. That seems like a great way to come to the most honest, well-supported, rational conclusion possible.



Quantum Materials Corp. (QTMM) Stock Research Links

QTMM Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Celebrating Innovative Thought Leadership: TLFT 2025 Awards

Updated Category News Views 401

Celebrating Innovative Thought Leadership Accenture, KPMG, and Elsevier have been honored for their groundbreaking accomplishments in thought leadership, showcasing their significant influence across brand development, social impact, and industry standards. Recognition at the TLFT 2025 Awards iResearch Services has proudly unveiled the winners of the prestigious TLFT 2025...

Continue Reading
Aquestive Therapeutics Boosts Stock Target After Event Insights

Updated Category News Views 57

Aquestive Therapeutics made headlines back in 2024 with its stock getting a price target bump to $10 from H.C. Wainwright. This was right after they rolled out updates at a virtual investor event where they pitched their cutting-edge Adrenaverse technology. Traders were buzzing—was this the kind of news that’d drive shares up? Turns out, it was more than just fluff;...

Continue Reading
Valneva Collaborates with LimmaTech on Shigella Vaccine Study

Updated Category News Views 63

Valneva Begins Clinical Trials for Innovative Shigella Vaccine Valneva SE, a prominent specialty vaccine company, and LimmaTech Biologics AG, a clinical-stage biotech firm, have recently marked a significant milestone in vaccine research. They announced the initial vaccination in a pivotal Phase 2b controlled human infection model (CHIM) study focused on their tetravalent...

Continue Reading
Innovative Vehicle Accessory Enhances Road Safety Efforts

Updated Category News Views 194

Introducing a Revolutionary Vehicle Safety Accessory Every day, drivers encounter various challenges on the road, from navigating busy intersections to spotting pedestrians or hidden traffic signs. An innovative inventor recognized these challenges and developed the CORNER CAMERA, an inventive solution aimed at improving road safety for everyone. Understanding the CORNER...

Continue Reading
California Northstate University Celebrates Key Accreditation Milestone

Updated Category News Views 159

California Northstate University Announces Full Accreditation California Northstate University (CNU) has achieved a significant milestone by securing full accreditation for its College of Medicine from the Liaison Committee on Medical Education (LCME). This achievement underscores CNU’s unwavering dedication to promoting educational excellence, innovation, and the...

Continue Reading